Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome

Experimental Cell Research

Volumn 319, Issue 14, 2013, Pages 2230-2243

  Sandberg, Cecilie Jonsgar ^a,b   Altschuler, Gabriel ^c   Jeong, Jieun ^c   Strømme, Kirsten Kierulf ^a   Stangeland, Biljana ^a   Murrell, Wayne ^a   Grasmo Wendler, Unn Hilde ^b   Myklebost, Ola ^b   Helseth, Eirik ^b   Vik Mo, Einar Osland ^a,b   Hide, Winston ^c   Langmoen, Iver A ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adult human neural stem cell; Cancer stem cell; Glioblastoma; Sfrp1; Survival; Wnt

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CELL; CANCER STEM CELL; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; GENE EXPRESSION; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEURAL STEM CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; WNT SIGNALING PATHWAY;

MUS;

EID: 84880747370     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.06.004     Document Type: Article

References (53)

1. Androutsellis-Theotokis A., Leker R.R., Soldner F., Hoeppner D.J., Ravin R., Poser S.W., Rueger M.A., Bae S.K., Kittappa R., McKay R.D. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006, 442:823-826.
2. Ben-David U., Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 2011, 11:268-277.
3. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
4. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., Morizane A., Bergquist F., Riebe I., Nannmark U., Carta M., Hanse E., Takahashi J., Sasai Y., Funa K., Brundin P., Eriksson P.S., Li J.Y. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006, 24:1433-1440.
5. Breitling R., Armengaud P., Amtmann A., Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004, 573:83-92.
6. Chen R., Nishimura M.C., Bumbaca S.M., Kharbanda S., Forrest W.F., Kasman I.M., Greve J.M., Soriano R.H., Gilmour L.L., Rivers C.S., Modrusan Z., Nacu S., Guerrero S., Edgar K.A., Wallin J.J., Lamszus K., Westphal M., Heim S., James C.D., VandenBerg S.R., Costello J.F., Moorefield S., Cowdrey C.J., Prados M., Phillips H.S. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010, 17:362-375.
7. Clement V., Sanchez P., de T.N., Radovanovic I., Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007, 17:165-172.
8. Engstrom P.G., Tommei D., Stricker S.H., Ender C., Pollard S.M., Bertone P. Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival. Genome Med. 2012, 4:76.
9. Eppert K., Takenaka K., Lechman E.R., Waldron L., Nilsson B., van G.P., Metzeler K.H., Poeppl A., Ling V., Beyene J., Canty A.J., Danska J.S., Bohlander S.K., Buske C., Minden M.D., Golub T.R., Jurisica I., Ebert B.L., Dick J.E. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 2011, 17:1086-1093.
10. Ernst A., Hofmann S., Ahmadi R., Becker N., Korshunov A., Engel F., Hartmann C., Felsberg J., Sabel M., Peterziel H., Durchdewald M., Hess J., Barbus S., Campos B., Starzinski-Powitz A., Unterberg A., Reifenberger G., Lichter P., Herold-Mende C., Radlwimmer B. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin. Cancer Res. 2009, 15:6541-6550.
11. Fan X., Khaki L., Zhu T.S., Soules M.E., Talsma C.E., Gul N., Koh C., Zhang J., Li Y.M., Maciaczyk J., Nikkhah G., Dimeco F., Piccirillo S., Vescovi A.L., Eberhart C.G. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010, 28:5-16.
12. Freije W.A., Castro-Vargas F.E., Fang Z., Horvath S., Cloughesy T., Liau L.M., Mischel P.S., Nelson S.F. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004, 64:6503-6510.
13. Gentles A.J., Plevritis S.K., Majeti R., Alizadeh A.A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2010, 304:2706-2715.
14. Gentles A.J., Plevritis S.K., Majeti R., Alizadeh A.A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2010, 304:2706-2715.
15. Georgantas R.W., Tanadve V., Malehorn M., Heimfeld S., Chen C., Carr L., Martinez-Murillo F., Riggins G., Kowalski J., Civin C.I. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res. 2004, 64:4434-4441.
16. Gould J., Getz G., Monti S., Reich M., Mesirov J.P. Comparative gene marker selection suite. Bioinformatics 2006, 22:1924-1925.
17. Gunther H.S., Schmidt N.O., Phillips H.S., Kemming D., Kharbanda S., Soriano R., Modrusan Z., Meissner H., Westphal M., Lamszus K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008, 27:2897-2909.
18. Helseth R., Helseth E., Johannesen T.B., Langberg C.W., Lote K., Ronning P., Scheie D., Vik A., Meling T.R. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol. Scand. 2010, 122:159-167.
19. Ho Sui S.J., Begley K., Reilly D., Chapman B., McGovern R., Rocca-Sera P., Maguire E., Altschuler G.M., Hansen T.A., Sompallae R., Krivtsov A., Shivdasani R.A., Armstrong S.A., Culhane A.C., Correll M., Sansone S.A., Hofmann O., Hide W. The Stem Cell discovery engine: an integrated repository and analysis system for cancer stem cell comparisons. Nucleic Acids Res. 2012, 40:D984-D991.
20. Ho Sui S.J., Begley K., Reilly D., Chapman B., McGovern R., Rocca-Sera P., Maguire E., Altschuler G.M., Hansen T.A., Sompallae R., Krivtsov A., Shivdasani R.A., Armstrong S.A., Culhane A.C., Correll M., Sansone S.A., Hofmann O., Hide W. The Stem Cell discovery engine: an integrated repository and analysis system for cancer stem cell comparisons. Nucleic Acids Res. 2012, 40:D984-D991.
21. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39:193-206.
22. Johansson C.B., Svensson M., Wallstedt L., Janson A.M., Frisen J. Neural stem cells in the adult human brain. Exp. Cell Res. 1999, 253:733-736.
23. Jones M.B., Chu C.H., Pendleton J.C., Betenbaugh M.J., Shiloach J., Baljinnyam B., Rubin J.S., Shamblott M.J. Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. Stem Cells Dev. 2010, 19:1923-1935.
24. Kim W., Liau L.M. IDH mutations in human glioma. Neurosurg. Clin. N. Am 2012, 23:471-480.
25. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK, The WHO classification of tumors of the nervous system. International Agency for Research on Cancer (IARC), Lyon, France. J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9.
26. Lai K., Kaspar B.K., Gage F.H., Schaffer D.V. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat. Neurosci. 2003, 6:21-27.
27. Laks D.R., Masterman-Smith M., Visnyei K., Angenieux B., Orozco N.M., Foran I., Yong W.H., Vinters H.V., Liau L.M., Lazareff J.A., Mischel P.S., Cloughesy T.F., Horvath S., Kornblum H.I. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 2009, 27:980-987.
28. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
29. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
30. Li A., Walling J., Ahn S., Kotliarov Y., Su Q., Quezado M., Oberholtzer J.C., Park J., Zenklusen J.C., Fine H.A. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res. 2009, 69:2091-2099.
31. Lie D.C., Colamarino S.A., Song H.J., Desire L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
32. + and C. Cancer Res. 2010, 70:2030-2040.
33. Majeti R., Becker M.W., Tian Q., Lee T.L., Yan X., Liu R., Chiang J.H., Hood L., Clarke M.F., Weissman I.L. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl. Acad. Sci. U.S.A 2009, 106:3396-3401.
34. Moe M.C., Varghese M., Danilov A.I., Westerlund U., Ramm-Pettersen J., Brundin L., Svensson M., Berg-Johnsen J., Langmoen I.A. Multipotent progenitor cells from the adult human brain: neurophysiological differentiation to mature neurons. Brain 2005, 128:2189-2199.
35. Moe M.C., Westerlund U., Varghese M., Berg-Johnsen J., Svensson M., Langmoen I.A. Development of neuronal networks from single stem cells harvested from the adult human brain. Neurosurgery 2005, 56:1182-1188.
36. Nakajima H., Ito M., Morikawa Y., Komori T., Fukuchi Y., Shibata F., Okamoto S., Kitamura T. Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells. Biochem. Biophys. Res. Commun. 2009, 390:65-70.
37. Nakano I., Masterman-Smith M., Saigusa K., Paucar A.A., Horvath S., Shoemaker L., Watanabe M., Negro A., Bajpai R., Howes A., Lelievre V., Waschek J.A., Lazareff J.A., Freije W.A., Liau L.M., Gilbertson R.J., Cloughesy T.F., Geschwind D.H., Nelson S.F., Mischel P.S., Terskikh A.V., Kornblum H.I. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J. Neurosci. Res. 2008, 86:48-60.
38. Nakano I., Paucar A.A., Bajpai R., Dougherty J.D., Zewail A., Kelly T.K., Kim K.J., Ou J., Groszer M., Imura T., Freije W.A., Nelson S.F., Sofroniew M.V., Wu H., Liu X., Terskikh A.V., Geschwind D.H., Kornblum H.I. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J. Cell Biol. 2005, 170:413-427.
39. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisica I., Dick J.E. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
40. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., Williams P.M., Modrusan Z., Feuerstein B.G., Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9:157-173.
41. Pico A.R., Kelder T., van Iersel M.P., Hanspers K., Conklin B.R., Evelo C. WikiPathways: pathway editing for the people. PLoS. Biol. 2008, 6:e184.
42. Prestegarden L., Svendsen A., Wang J., Sleire L., Skaftnesmo K.O., Bjerkvig R., Yan T., Askland L., Persson A., Sakariassen P.O., Enger P.O. Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res. 2010, 70:4274-4279.
43. Rahman M., Deleyrolle L., Vedam-Mai V., Azari H., Abd-El-Barr M., Reynolds B.A. The cancer stem cell hypothesis: failures and pitfalls. Neurosurgery 2011, 68:531-545.
44. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
45. Sun L., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H.A. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9:287-300.
46. Suva M.L., Riggi N., Janiszewska M., Radovanovic I., Provero P., Stehle J.C., Baumer K., Le Bitoux M.A., Marino D., Cironi L., Marquez V.E., Clement V., Stamenkovic I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009, 69:9211-9218.
47. Taussig D.C., Miraki-Moud F., Anjos-Afonso F., Pearce D.J., Allen K., Ridler C., Lillington D., Oakervee H., Cavenagh J., Agrawal S.G., Lister T.A., Gribben J.G., Bonnet D. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008, 112:568-575.
48. Taussig D.C., Vargaftig J., Miraki-Moud F., Griessinger E., Sharrock K., Luke T., Lillington D., Oakervee H., Cavenagh J., Agrawal S.G., Lister T.A., Gribben J.G., Bonnet D. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 2010, 115:1976-1984.
49. Varghese M., Olstorn H., Sandberg C., Vik-Mo E.O., Noordhuis P., Nister M., Berg-Johnsen J., Moe M.C., Langmoen I.A. A comparison between stem cells from the adult human brain and from brain tumors. Neurosurgery 2008, 63:1022-1033.
50. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., Alexe G., Lawrence M., O'Kelly M., Tamayo P., Weir B.A., Gabriel S., Winckler W., Gupta S., Jakkula L., Feiler H.S., Hodgson J.G., James C.D., Sarkaria J.N., Brennan C., Kahn A., Spellman P.T., Wilson R.K., Speed T.P., Gray J.W., Meyerson M., Getz G., Perou C.M., Hayes D.N. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
51. Vik-Mo E.O., Sandberg C., Olstorn H., Varghese M., Brandal P., Ramm-Pettersen J., Murrell W., Langmoen I.A. Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro. Oncol. 2010, 12:1220-1230.
52. Wang J., Sakariassen P.O., Tsinkalovsky O., Immervoll H., Boe S.O., Svendsen A., Prestegarden L., Rosland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., Enger P.O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 2008, 122:761-768.
53. Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., Maitland A., Mostafavi S., Montojo J., Shao Q., Wright G., Bader G.D., Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010, 38:W214-W220.